Controlled Human Malaria Infection evaluation of Plasmodium falciparum malaria vaccine ProC6C-AlOH/Matrix-Mtm in healthy Malian adults

计划入组 34 人

Adjuvanting Viral Vectored Malaria Vaccines With Matrix M

计划入组 23 人 · 首次发布于 2012 年 8 月 21 日

Safety and Immunogenicity of RH5.1/Matrix-M in Adults and Infants Living in Tanzania

计划入组 60 人 · 首次发布于 2020 年 3 月 23 日

The ProC6C-AlOH/Matrix-M vaccine(University Of The Sciences, Techniques And Technologies Of Bamako)

ProC6C-AlOH

Matrix-M

Moerae Matrix, Inc.

United States

Matrix Biomed, Inc.

United States

3-D Matrix Ltd.

Japan

Multistage Malaria Vaccine Achieves 54% Efficacy in Phase 2 Trial Among Malian Adults

Blood-stage Malaria Vaccine Candidate RH5.1/Matrix-M Trial in Tanzania

RH5.1/Matrix-M Vaccine Shows Promising Efficacy Against Malaria in African Children